您当前所在的位置:首页 > 产品中心 > 产品信息
Oxyphenbutazone_分子结构_CAS_129-20-4)
点击图片或这里关闭

Oxyphenbutazone

产品号 DB03585 公司名称 DrugBank
CAS号 129-20-4 公司网站 http://www.ualberta.ca/
分子式 C19H20N2O3 电 话 (780) 492-3111
分子量 324.3737 传 真
纯 度 电子邮件 david.wishart@ualberta.ca
保 存 Chembase数据库ID: 3246

产品价格信息

请登录

产品别名

标题
Oxyphenbutazone
IUPAC标准名
4-butyl-1-(4-hydroxyphenyl)-2-phenylpyrazolidine-3,5-dione
IUPAC传统名
cinophen-N
商标名
Flogistin
Flanaril
Butanora
Oxalid
Optimal
Tanderil
Cinophen-n
Crovaril
Infammil
Oxazolioin
Pirabutina
Portoril
Tandacote
Tandearil
Telidac
Telidal
Butaflogin
Butazonic
Butilene
Etrozolidina
Flogoril
Flogostop
Genal
Idrobutazina
Infamil
Metabolite I
Mysite
Neo-farmadol
Offitril
Oxyphentamin
Tanderal
Tendearil
Visubutina
Aradinum
Artroflog
Butanova
Butapirone
Californit
Deflogin
Flamaril
Flegmostam
Flogal
Floghene
Flogitolo
Flogodin
Flopirina
Frabel
Ipabutona
Iridil
Isobutazina
Isobutil
Neofen
Oxazolidin
Oxazolidin-geigy
Oxi-fenibutol
Oxibutol
Oxybuton
Piraflogin
Poliflogil
Rapostan
Remazin
Reumox
Reunabutal
Rumapax
Tandalgesic
Valioil
别名
Ossifenbutazone [dcit]
1-(p-Hydroxyphenyl)-2-phenyl-4-butyl-3,5-pyrazolidinedione
1-Phenyl-2-(p-hydroxyphenyl)-3,5-dioxo-4-butylpyrazolidine
3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl
4-Butyl-1-(4-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione
4-Butyl-2-(p-hydroxyphenyl)-1-phenyl-3,5-pyrazolidinedione
Oxifenbutazona [inn-spanish]
P-hydroxyphenylbutazone
1-p-Hydroxyphenyl-2-phenyl-3,5-dioxo-4-N-butylpyrazolidine
4-Butyl-1-(p-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione
4-Butyl-2-(4-hydroxyphenyl)-1-phenyl-3,5-dioxopyrazolidine
Hydroxyphenylbutazon
OPB
Oxifenylbutazon
Oxiphenbutazone
Oxiphenbutazonum
Oxyphenbutazonum [inn-latin]
Oxyphenobutazone
Oxyphenylbutazone
P-oxyphenylbutazone
Usaf Ge-14

产品登记号

PubChem CID 4641
CAS号 129-20-4
PubChem SID 46507285

产品性质

疏水性(logP) 2.72 [HANSCH,C ET AL. (1995)]
溶解度 0.06 mg/mL at 30 oC [YALKOWSKY,SH & DANNENFELSER,RM (1992)]

产品详细信息

详细说明 (English)
Item Information
Drug Groups experimental; withdrawn
Description Oxyphenbutazone was withdrawn from the Canadian market in March 1985 due to concerns regarding bone marrow suppression.
External Links
Wikipedia

参考文献